Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low-risk cigarettes: a prescription

G B Gori

    Science (New York, N.Y.)
    |December 11, 1976
    PubMed
    Summary

    Reducing toxic smoke components and overall intake can lower smoking-related diseases. Developing less hazardous cigarettes with modified flavors is feasible, potentially reducing risks for continuing smokers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The costly illusion of regulating unknowable risks.

    Regulatory toxicology and pharmacology : RTP·2002
    Same author

    Individualized or population risks: what is the argument?

    American journal of public health·2001
    Same author

    Financial interests are not the only bias factor.

    Nature·2001
    Same author

    Trojan horses.

    Science (New York, N.Y.)·2000
    Same author

    In search of hypotheses.

    Nutrition and cancer·1999
    Same author

    Environmental tobacco smoke and lung cancer among nonsmokers.

    Epidemiology (Cambridge, Mass.)·1999

    Area of Science:

    • Public Health
    • Toxicology
    • Product Development

    Background:

    • Antismoking campaigns have limited success, with 55-60 million American smokers and rising rates among teens and women.
    • Continued smoking poses significant health risks, necessitating strategies to protect individuals who persist in smoking.

    Purpose of the Study:

    • To explore the feasibility of developing less hazardous cigarettes.
    • To define limits for cigarette and smoke composition that approach relative safety.
    • To estimate critical smoke intake doses where smoking risks approach nonsmoker levels.

    Main Methods:

    • Analyzing dose-response evidence from epidemiological studies.
    • Extrapolating blood concentrations of smoke components (e.g., carbon monoxide) at different intake rates.
    • Applying developed technology to commercial cigarette manufacturing.

    Main Results:

    • Technology exists to reduce toxic smoke components and total smoke intake.
    • Modified cigarettes may alter traditional flavor profiles, requiring consumer perception shifts and added flavors/fragrances.
    • Dose-response analysis and extrapolation can define critical smoke intake limits.

    Conclusions:

    • Less hazardous cigarettes can be manufactured, offering reduced risk for continuing smokers.
    • Defining and shifting consumption towards specific smoke intake limits can substantially decrease smoking-related diseases.
    • These limits indicate reduced risk levels, not absolute safety, for smokers.

    Related Experiment Videos